ARCHIVES

Funding Opportunities

This article is from The Cancer Letter archive.

Vol. 28 No. 45 | December 6, 2002

Download PDF Visit The Full Archive

Related Articles

ASCO Annual Meeting: PARP Inhibitors Show Promise Against Breast Cancer In Small Phase II Studies

June 5, 2009

Zevalin Regimen Better Than Rituximab Alone For NHL

June 29, 2001

DePinho Will Not Meet With AAUP In Probe of Tenure Denial Dispute

September 19, 2014

ACS Research Budget Over $82 Million

July 17, 1987

Senate Voices Discontent With NIH, NCI Budget; Gorton Presses Raub On Cancer’s ‘Low Priority’

March 22, 1991

FDA Grants Approvals to Lynparza, Blincyto, Xgeva, Gardasil 9 and Cyramza

December 26, 2014